Ternary combination of irinotecan, fluorouracil-folinic acid and oxaliplatin: results on human colon cancer cell lines

類似資料

• Impact of the oxaliplatin-5 fluorouracil-folinic acid combination on respective intracellular determinants of drug activity
  著者:: Fischel, J L, 等
  出版事項: (2002)
• Safety and efficacy of weekly 5-fluorouracil/folinic acid/oxaliplatin/irinotecan in the first-line treatment of gastrointestinal cancer
  著者:: Peinert, Stefan, 等
  出版事項: (2010)
• Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.
  著者:: Etienne, M. C., 等
  出版事項: (1991)
• Critical factors for the reversal of methotrexate cytotoxicity by folinic acid.
  著者:: Bernard, S., 等
  出版事項: (1991)
• Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment
  著者:: Zoetemelk, Marloes, 等
  出版事項: (2020)